Data as of Aug 25, 2026 · Based on 3,181,687 AI responses across 10,525 prompts · See how Parse measures this
CABTREO is the first FDA-approved fixed-dose triple-combination topical gel for treating acne vulgaris in patients aged 12 and older, containing clindamycin phosphate, adapalene, and benzoyl peroxide. It is applied once daily as a single prescription product.
Parse Score